Resonant Capital Advisors’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.68M Sell
106,267
-531
-0.5% -$13.4K 0.13% 112
2026
Q1
$2.71M Buy
106,798
+5,930
+6% +$151K 0.14% 104
2025
Q4
$2.57M Buy
100,868
+6,828
+7% +$174K 0.14% 107
2025
Q3
$2.4M Buy
94,040
+41,757
+80% +$1.06M 0.14% 113
2025
Q2
$1.33M Buy
52,283
+7,138
+16% +$180K 0.08% 142
2025
Q1
$1.14M Buy
45,145
+1,008
+2% +$25.3K 0.08% 143
2024
Q4
$1.1M Buy
44,137
+13,403
+44% +$337K 0.08% 144
2024
Q3
$785K Buy
30,734
+6,245
+26% +$157K 0.06% 171
2024
Q2
$607K Buy
24,489
+6,097
+33% +$150K 0.05% 184
2024
Q1
$458K Buy
+18,392
New +$458K 0.04% 205

Other funds holding IBDT

Resonant Capital Advisors's IBDT Position: Q2 2026 in Review

Resonant Capital Advisors reduced its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 0.5% in Q2 2026, selling an estimated $13.4K and leaving 106,267 shares worth $2.68M. The position accounts for 0.13% of the portfolio, ranked #112.

Resonant Capital Advisors first reported a position in IBDT in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.71M in Q1 2026. 247 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Resonant Capital Advisors held 106,267 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $2.68M as of Q2 2026.
  • Resonant Capital Advisors sold 531 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $13.4K.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.13% of Resonant Capital Advisors's portfolio in Q2 2026, its #112 holding.
  • Resonant Capital Advisors first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • Resonant Capital Advisors's iShares iBonds Dec 2028 Term Corporate ETF position peaked at $2.71M in Q1 2026.
  • 247 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.